Back to search

Article

Peptides Based Vaccine Against SARS-nCoV-2 Antigenic Fragmented Synthetic Epitopes Recognized by T-Cell and β-Cell initiate Specific Antibody to Fight the Infection

2020-09-03

Abstract excerpt

The World Health Organization has declared the rapidly spreading coronavirus to be a global pandemic. The FDA till yet approved a vaccine for human novel coronavirus. Here we developed a peptide-based vaccine and used high throughput screening by molecular dynamics simulation to identify T-cell and β-cell recognized epitopes to the production of specific antibodies against SARS-nCoV-2. We construct ~12 P` antigeni...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b92a74cd-603a-51c5-8631-3b7ab7e9c359
DOI
10.21203/rs.3.rs-70668/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Peptides Based Vaccine Against SARS-nCoV-2 Antigenic Fragmented Synthetic Epitopes Recognized by T-Cell and β-Cell initiate Specific Antibody to Fight the InfectionDOI 10.21203/rs.3.rs-70668/v1
Peptide-based epitope design on non-structural proteins of SARS-CoV-2Semantic proximity
The multi-epitope vaccine prediction to combat Pandemic SARS-CoV-2, an immunoinformatic approachSemantic proximity
Whole proteome screening and identification of potential epitopes of SARS-CoV-2 for vaccine design-an immunoinformatic, molecular docking and molecular dynamics simulation accelerated robust strategySemantic proximity
Immunoinformatic approach to design a vaccine against SARS-COV-2 membrane glycoproteinSemantic proximity
Design and Immune Profile of Multi-Epitope Synthetic Antigen Vaccine Against SARS-CoV-2: An In Silico and In Vivo ApproachSemantic proximity
Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain: <i>In silico</i> analysisSemantic proximity
Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics analysisSemantic proximity
Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopesSemantic proximity
Immunoinformatics and molecular modeling approach to design universal multi-epitope vaccine for SARS-CoV-2Semantic proximity
Designing a multi-epitope peptide based vaccine against SARS-CoV-2Semantic proximity
Multi-epitope Based Peptide Vaccine Design Using Three Structural Proteins (S, E, and M) of SARS-CoV-2: An <i>In Silico</i> ApproachSemantic proximity
Genome based Evolutionary study of SARS-CoV-2 towards the Prediction of Epitope Based Chimeric VaccineSemantic proximity
Select a neighboring publication to make it the new centre.